Search Results

You searched for : Octapharma

	Positive Results From ProDERM Study of octagamÂ® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020 Octapharma announces that the final results from the phase III ProDERM study will be presented at the American College of Rheumatology (ACR) Convergence 2020 virtual ... Nov 07
	Octapharma announces FDA approval of updated NUWIQÂ® Prescribing Information to include immunogenicity data in previously untreated patients The development of inhibitors against exogenous FVIII can reduce the effectiveness of treatment and negatively impact a patient's long-term joint health and quality ... Oct 20
	Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019 Octapharma has seven R&D sites and six state-of-the-art manufacturing facilities in Austria, France, Germany, Mexico and Sweden, in addition to more ... Feb 17
	Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders Octapharma demonstrates commitment to improving haemophilia, a treatment at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)... Feb 08
	Update of Summary of Product Characteristics for NuwiqÂ® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis Octapharma announced today that the European Medicines Agency has authorised an updated Summary of Product Characteristics (SmPC) for NuwiqÂ® that includes information on personalised prophylaxis ... Oct 01
5 Matching result(s) found!

-Advertisements-

Trending Now
	The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
	Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
	Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
	When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
	Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
	Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
	Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
	Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
	Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
	Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
	Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
	Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
	Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
	Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
	Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
	Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
	Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
	TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
	The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
	Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024

Search Results

Positive Results From ProDERM Study of octagamÂ® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020

Octapharma announces FDA approval of updated NUWIQÂ® Prescribing Information to include immunogenicity data in previously untreated patients

Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019

Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders

Update of Summary of Product Characteristics for NuwiqÂ® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis

Trending Now